The HIV Prevention Trials Network develops and tests the safety and efficacy of primarily non-vaccine interventions designed to prevent the transmission of HIV.
Main Areas of Focus
- To discover and develop new and innovative research strategies to reduce the acquisition and transmission of HIV
The Executive Committee is made up of: Principal Investigators (PIs), International Lead Investigator, Past PI and Co-PI, SDMC PI & LC PI, LOC Director, Community Representative, two NIH Representatives, and two Site Representatives.
Read more about this network: HIV Prevention Trials Network (HPTN)
HPTN has 90 clinical research sites in more than 15 countries around the world.
HPTN holds an annual meeting as well as regular regional meetings.